Linchong Sun

3.8k total citations · 3 hit papers
35 papers, 2.3k citations indexed

About

Linchong Sun is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Linchong Sun has authored 35 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Linchong Sun's work include Cancer, Hypoxia, and Metabolism (15 papers), RNA modifications and cancer (10 papers) and Immune cells in cancer (6 papers). Linchong Sun is often cited by papers focused on Cancer, Hypoxia, and Metabolism (15 papers), RNA modifications and cancer (10 papers) and Immune cells in cancer (6 papers). Linchong Sun collaborates with scholars based in China, United States and Poland. Linchong Sun's co-authors include Ping Gao, Huafeng Zhang, Caixia Suo, Xiaoping He, Shiting Li, Xiuying Zhong, Libing Song, Shengqi Shen, De Huang and Gongwei Wu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Linchong Sun

32 papers receiving 2.3k citations

Hit Papers

Metabolic reprogramming and epigene... 2014 2026 2018 2022 2021 2014 2024 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linchong Sun China 22 1.7k 1.2k 297 288 238 35 2.3k
Yekaterina Y. Zaytseva United States 24 1.4k 0.8× 1.0k 0.8× 368 1.2× 177 0.6× 144 0.6× 49 2.1k
Dimitrios Anastasiou United Kingdom 15 1.7k 1.0× 981 0.8× 384 1.3× 196 0.7× 206 0.9× 30 2.5k
Alba Luengo United States 11 1.8k 1.1× 1.4k 1.2× 396 1.3× 170 0.6× 172 0.7× 15 2.5k
Evan C. Lien United States 17 1.4k 0.8× 777 0.6× 393 1.3× 207 0.7× 143 0.6× 28 2.0k
Guishuai Lv China 15 1.3k 0.8× 1.0k 0.8× 330 1.1× 180 0.6× 305 1.3× 18 2.0k
Taro Hitosugi United States 21 1.6k 1.0× 1.1k 0.9× 269 0.9× 104 0.4× 218 0.9× 34 2.1k
Kelly M. Kennedy United States 7 1.6k 1.0× 1.6k 1.3× 359 1.2× 126 0.4× 203 0.9× 7 2.3k
Xueli Bian China 9 902 0.5× 792 0.6× 169 0.6× 207 0.7× 194 0.8× 15 1.4k
Mei Yi China 21 1.4k 0.9× 808 0.6× 442 1.5× 279 1.0× 358 1.5× 49 2.1k
Suveera Dhup Belgium 9 1.3k 0.8× 1.1k 0.9× 282 0.9× 94 0.3× 173 0.7× 13 1.8k

Countries citing papers authored by Linchong Sun

Since Specialization
Citations

This map shows the geographic impact of Linchong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linchong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linchong Sun more than expected).

Fields of papers citing papers by Linchong Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linchong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linchong Sun. The network helps show where Linchong Sun may publish in the future.

Co-authorship network of co-authors of Linchong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Linchong Sun. A scholar is included among the top collaborators of Linchong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linchong Sun. Linchong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Tong, Ping Gao, & Linchong Sun. (2025). Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies. SHILAP Revista de lepidopterología. 4(4).
2.
Li, Zhikun, Caixia Suo, Xuemei Gu, et al.. (2025). ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism. Journal of Molecular Cell Biology. 17(1).
3.
Sun, Linchong, et al.. (2025). Environmental pollutants cause placental dysfunctions to induce miscarriage. 3(4). 100162–100162.
4.
Li, Hongde, et al.. (2024). Lactylation in cancer: Current understanding and challenges. Cancer Cell. 42(11). 1803–1807. 77 indexed citations breakdown →
5.
Ma, Wenhao, Yuchen Sun, Ronghui Yan, et al.. (2024). OXCT1 functions as a succinyltransferase, contributing to hepatocellular carcinoma via succinylating LACTB. Molecular Cell. 84(3). 538–551.e7. 43 indexed citations
6.
Hao, Yijie, Zilong Zhou, Rui Liu, et al.. (2024). Mitochondria-localized MBD2c facilitates mtDNA transcription and drug resistance. Nature Chemical Biology. 21(6). 926–938. 5 indexed citations
7.
Sun, Linchong, Caixia Suo, Tong Zhang, et al.. (2023). ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism. Nature Chemical Biology. 19(12). 1492–1503. 30 indexed citations
8.
Suo, Caixia, Haoran Wei, Xuemei Gu, et al.. (2022). Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5. Frontiers in Oncology. 12. 857968–857968. 18 indexed citations
9.
Liu, Zhaoji, Linchong Sun, Yongping Cai, et al.. (2021). Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1. Cancer Research. 81(5). 1265–1278. 42 indexed citations
10.
Wei, Haoran, Wenhao Ma, Xiaofei Lü, et al.. (2021). KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progression. Cancer Communications. 41(9). 904–920. 35 indexed citations
11.
Wu, Gongwei, Caixia Suo, Ying Yang, et al.. (2021). MYC promotes cancer progression by modulating m 6 A modifications to suppress target gene translation. EMBO Reports. 22(3). e51519–e51519. 33 indexed citations
12.
Sun, Linchong, Huafeng Zhang, & Ping Gao. (2021). Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein & Cell. 13(12). 877–919. 480 indexed citations breakdown →
13.
Wang, Yinghui, Hui Lü, Linchong Sun, et al.. (2021). Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase. Cell Death and Disease. 12(10). 902–902. 13 indexed citations
14.
Zhang, Tong, Linchong Sun, Yijie Hao, et al.. (2021). ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nature Cancer. 3(1). 75–89. 138 indexed citations
15.
Xing, Songge, Zhaoyong Li, Wenhao Ma, et al.. (2019). DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing. Cancer Research. 79(19). 4923–4936. 38 indexed citations
16.
Sun, Linchong, Caixia Suo, Shiting Li, Huafeng Zhang, & Ping Gao. (2018). Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870(1). 51–66. 289 indexed citations
17.
Wu, Gongwei, Shengqi Shen, Xiaoyu Ma, et al.. (2017). Menin enhances c-Myc-mediated transcription to promote cancer progression. Nature Communications. 8(1). 15278–15278. 46 indexed citations
18.
Zhong, Xiuying, Xiang Zhang, Xinwei Diao, et al.. (2017). CUE domain‐containing protein 2 promotes the Warburg effect and tumorigenesis. EMBO Reports. 18(5). 809–825. 19 indexed citations
19.
Yang, Dongdong, Linchong Sun, Zhaoyong Li, & Ping Gao. (2016). Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming. Advances in experimental medicine and biology. 927. 191–215. 36 indexed citations
20.
Sun, Linchong, Libing Song, Qianfen Wan, et al.. (2015). cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Research. 25(4). 429–444. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026